Titre:
  • Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
Auteur:Woff, Erwin; Hendlisz, Alain; Garcia, Camilo; Deleporte, Amélie; Delaunoit, Thierry; Marechal, Raphaël; Holbrechts, S.; Van Den Eynde, Marc; Demolin, Gauthier; Vierasu, Irina; Lhommel, Renaud; Gauthier, Namur; Guiot, Thomas; Ameye, Lieveke; Flamen, Patrick
Informations sur la publication:European journal of nuclear medicine and molecular imaging, 43, 10, page (1792-1801)
Statut de publication:Publié, 2016-09
Sujet CREF:Imagerie médicale, radiologie, tomographie
Mots-clés:Early metabolic response assessment
FDG PET-CT
Metastatic colorectal cancer
Targeted therapy
Tumoral heterogeneity
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Capecitabine -- administration & dosage
Colorectal Neoplasms -- diagnostic imaging -- drug therapy -- secondary
Drug Monitoring -- methods
Female
Fluorodeoxyglucose F18 -- pharmacokinetics
Humans
Male
Middle Aged
Molecular Targeted Therapy -- methods
Niacinamide -- administration & dosage -- analogs & derivatives
Phenylurea Compounds -- administration & dosage
Positron Emission Tomography Computed Tomography -- methods
Radiopharmaceuticals -- pharmacokinetics
Reproducibility of Results
Sensitivity and Specificity
Sorafenib
Treatment Outcome
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1619-7070
info:doi/10.1007/s00259-016-3365-x
info:pii/10.1007/s00259-016-3365-x
info:scp/84963685661
info:pmid/27072811
PMC4969337